Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:COV

(COV) (COV) Stock Price, News & Analysis

(COV) logo

About (COV) Stock (NYSE:COV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
3.88 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Receive COV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (COV) and its competitors with MarketBeat's FREE daily newsletter.

COV Stock News Headlines

Please take this warning seriously...
I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as January 29th… Meaning you don’t have much time to prepare.
See More Headlines

COV Stock Analysis - Frequently Asked Questions

(COV) (NYSE:COV) posted its earnings results on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.13. The business's revenue was up 6.8% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that (COV) investors own include Bristol-Myers Squibb (BMY), Pfizer (PFE), Chevron (CVX), Intel (INTC), Johnson & Johnson (JNJ), Boeing (BA) and CVS Health (CVS).

Company Calendar

Last Earnings
11/05/2014
Today
1/22/2025

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
CUSIP
G2554F11
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NYSE:COV) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners